Prostate Cancer VL

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

Details
In this slide presentation, Stephen Williams details using biomarkers to determine when to biopsy and when to repeat a prostate biopsy specifically: PSA, PHI, 4K, PCA3 and Confirm MDx. He overviews the patient journey pre and post biopsy and the process of determining which patients need a rebiopsy. Biography: Stephen B. Williams, MD Assistant Professor in Urology, Tenure-Track, Robert Earl Cone P...

Definitive Cryotherapy for Localized Prostate Cancer - J Stephen Jones

Details
Biography: J. Stephen Jones, MD, began his role as President of Cleveland Clinic Regional Hospitals and Family Health Centers in December 2014. When he took that role, there were nine regional hospitals and 18 family health centers. Two years later, Dr. Jones oversees 11 hospitals and more than 20 family health centers. Dr. Jones has published more than 200 articles in all major urological journal...

Adverse Effects of Androgen Deprivation Therapy - Matthew R. Smith

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Best Use of "Old and Cheap” Drugs- Ian F. Tannock

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Pharmacokinetics and Tolerance of Prostate Cancer Drugs in Japan and Other Asian countries - Hiroyoshi Suzuki

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

PSMA PET in Prostate Cancer: Steve Cho

Details
Prostate-specific membrane antigen (PSMA) has received a resurgence of attention as a useful biomarker in the imaging evaluation of prostate cancer with PET. Philip Koo, MD, welcomes Steve Cho, MD to discuss PSMA PET in prostate cancer for the inaugural lecture for the Imaging Center of Excellence on UroToday. Dr. Cho's discusses the number of agents that are being developed in prostate cancer and...

Welcome Address from Silke Gillessen and Aurelius Omlin at the Advanced Prostate Cancer Consensus Conference

Details
The co-founders of the 2017 Advanced Prostate Cancer Consensus Conference (APCCC), Silke Gillessen and Aurelius Omlin, discuss with Neal Shore different learnings from the 2015 APCCC and how it prepared them for the 2017 meeting. In addition, discussion on the number of countries that are represented and different types of specialists that attended the conference this year. The concept of the modi...

Phase 2 Study of the Safety and Antitumor Activity of Apalutamide in the High-risk Nonmetastatic Castration-resistant Prostate Cancer - Charles Ryan

Details
Journal Club: Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort. European Urology Charles Ryan, MD discusses the androgen receptor antagonist apalutamide was safe in patients with high-risk nonmetastatic castration-resistant prostate cancer and, based on dura...

Imaging of Metastatic Prostate Cancer- Anwar Padhar

Details
This video lecture presentations took place at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), in Lisbon, Portugal between in October 2016. The meeting was organised by Bioscript and the Scientific Committee, composed of Professors Laurence Klotz (Chair), Noel Clarke, Karim Fizazi and Bertrand Tombal. Anwar Padhar, MD, discusses the impact of imaging in diagnosing metastatic prosta...

Predicting survival of men with prostate cancer after radical prostatectomy- Axel Merseburger

Details
The presentations listed here were made at the 6th Symposium on the Treatment of Prostate Cancer (STOP-6), which was held in Lisbon, Portugal between the 14th and 16th October. Dr. Axel Merseburger presentation on predicting survival of men with prostate cancer after radical prostatectomy reviews the traditional pre-operative predictors in addition to the combination of pre and post operative clin...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe